HAL vs RAPT · P/E 9.3, $19.05B cap vs $132.1M cap
Halliburton Company (HAL) versus RAPT Therapeutics Inc (RAPT) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. RAPT currently screens at market cap $132.1M.
Not investment advice. Open the HAL and RAPT stock pages for the full models.
Not investment advice.